Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.27
+0.47 (1.63%)
Jul 28, 2026, 1:33 PM EDT - Market open
Genmab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,901 | 3,720 | 3,121 | 2,390 | 2,088 | 1,287 | |
Revenue Growth | 27.49% | 19.19% | 30.59% | 14.48% | 62.20% | -22.45% |
Cost of Revenue | 261 | 238 | 143 | 33 | - | - |
Gross Profit | 3,640 | 3,482 | 2,978 | 2,357 | 2,088 | 1,287 |
Selling, General & Admin | 666 | 626 | 549 | 478 | 385.16 | 196.2 |
Research & Development | 1,687 | 1,606 | 1,414 | 1,107 | 800.55 | 639.39 |
Other Operating Expenses | 230 | 185 | 43 | - | - | - |
Total Operating Expenses | 2,583 | 2,417 | 2,006 | 1,585 | 1,186 | 835.59 |
Operating Income | 1,057 | 1,065 | 972 | 772 | 902.02 | 451.59 |
Interest Income | 354 | 408 | 645 | 299 | 459 | 254.93 |
Interest Expense | -377 | -269 | -291 | -254 | -361.41 | -107.35 |
Total Non-Operating Income (Expense) | -23 | 139 | 354 | 45 | 97.59 | 147.57 |
Pretax Income | 905 | 1,204 | 1,326 | 817 | 999.61 | 599.17 |
Provision for Income Taxes | 168 | 241 | 193 | 186 | 214.89 | 146.96 |
Net Income | 737 | 963 | 1,133 | 631 | 784.72 | 452.2 |
Net Income to Common | 737 | 963 | 1,133 | 631 | 784.72 | 452.2 |
Net Income Growth | 89.46% | -15.00% | 79.56% | -19.59% | 73.53% | -42.10% |
Shares Outstanding (Basic) | 552 | 622 | 642 | 653 | 654 | 654 |
Shares Outstanding (Diluted) | 559 | 627 | 647 | 659 | 660 | 660 |
Shares Change | -13.51% | -3.04% | -1.88% | -0.17% | -0.06% | 0.24% |
EPS (Basic) | 1.33 | 1.55 | 1.77 | 0.97 | 1.20 | 0.69 |
EPS (Diluted) | 1.32 | 1.54 | 1.75 | 0.96 | 1.19 | 0.68 |
EPS Growth | -25.16% | -12.32% | 82.98% | -19.50% | 75.00% | -42.86% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 584 | 1,149 | 1,099 | 1,018 | 517.44 | 302.18 |
Free Cash Flow Growth | -25.42% | 4.55% | 7.96% | 96.74% | 71.23% | -69.95% |
Free Cash Flow Per Share | 1.04 | 1.83 | 1.70 | 1.54 | 0.78 | 0.46 |
Gross Margin | 93.31% | 93.60% | 95.42% | 98.62% | 100.00% | 100.00% |
Operating Margin | 27.10% | 28.63% | 31.14% | 32.30% | 43.21% | 35.08% |
Profit Margin | 18.89% | 25.89% | 36.30% | 26.40% | 37.59% | 35.13% |
FCF Margin | 14.97% | 30.89% | 35.21% | 42.59% | 24.78% | 23.48% |
EBITDA | 1,120 | 1,136 | 1,032 | 815 | 954.13 | 489.52 |
EBITDA Margin | 28.71% | 30.54% | 33.07% | 34.10% | 45.70% | 38.03% |
EBIT | 1,057 | 1,065 | 972 | 772 | 902.02 | 451.59 |
EBIT Margin | 27.10% | 28.63% | 31.14% | 32.30% | 43.21% | 35.08% |
Effective Tax Rate | 18.56% | 20.02% | 14.56% | 22.77% | 21.50% | 24.53% |